PODCAST: Big merger in the pharmaceutical industry
Airing on Thursday, May 7, 2015: One of the world’s biggest drug companies has moved to outsource the process of deciding who is allowed into its experimental drug trials.Johnson & Johnson is setting up what’s called a “compassionate use” panel to help it make these life & death decisions. Staying in the theme of pharmaceuticals, Alexion announced it was buying Syngeva for $8.4 billion earlier this week. And it’s election day in the U.K. today. Inequality has been a key theme of the campaign. We’ll see how tax loopholes impact the results today.
Stories You Might Like
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
